Shots:
- Abbott received US FDA approval for updates to the CardioMEMS HF System, enabling patients in the US to view their pulmonary artery pressure (PAP) readings through the CardioGuide HF App
- The updated system includes Dynamic Treatment Plan (DTP), allowing care teams to create personalized medication adjustment plans based on changes in PAP and send treatment instructions directly to pts. through the app
- The new capabilities are designed to help pts. better understand and manage heart failure, stay connected with care teams between visits, and support earlier treatment adjustments; Abbott plans to make the CardioGuide HF App and DTP available later in 2026
Ref: Abbott | Image: Abbott | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information connect with us at connect@pharmashots.com
